Insulin receptor substrate-4 is overexpressed in colorectal cancer and promotes retinoblastoma-cyclin-dependent kinase activation.
Patricia Sanmartín-SalinasMaría Del Val Toledo LoboFernando Noguerales-FraguasMiguel Toro LondoñoAntonio Jiménez-RuizLuis Gonzalez GuijarroPublished in: Journal of gastroenterology (2018)
Taken together, our findings suggest that IRS-4 promotes retinoblastoma-cyclin-dependent kinase activation and it may serve as a pharmacological target since its expression is very low in normal tissue, including colonic epithelium.